CTLA-4 is a second receptor for the B cell activation antigen B7.

Linsley, P S, Brady, W, Urnes, M, Grosmaire, L S, Damle, N K, Ledbetter, J A·1991·The Journal of experimental medicine
DOI 10.1084/jem.174.3.561

Cited by (1,000)

Items 401–500 of 1,000

  1. Functional Expression of a Costimulatory B7.2 (CD86) Protein on Human Salivary Gland Epithelial Cells that Interacts with the CD28 Receptor, but Has Reduced Binding to CTLA4
    Efstathia K. Kapsogeorgou, Haralampos Μ. Moutsopoulos, Menelaos N. Manoussakis · 2001 · The Journal of Immunology
  2. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis
    Bohuslav Melichar, M A Nash, Renato Lenzi, Chris D. Platsoucas, Ralph S. Freedman · 2000 · Clinical & Experimental Immunology
  3. Characterization of Accessory Molecules in Murine Lung Dendritic Cell Function: Roles for CD80, CD86, CD54, and CD40L
    Barbara J. Masten, Jennifer L. Yates, A M Pollard Koga, Mary F. Lipscomb · 1997 · American Journal of Respiratory Cell and Molecular Biology
  4. CD22-mediated stimulation of T cells regulates T-cell receptor/CD3-induced signaling.
    Alejandro A. Aruffo, Steven Brian Kanner, Dennis C. Sgroi, Jeffrey A. Ledbetter, Ivan Stamenkovic · 1992 · Proceedings of the National Academy of Sciences
  5. Human Dendritic Cells Discriminate Between Viable and Killed Toxoplasma gondii Tachyzoites: Dendritic Cell Activation After Infection with Viable Parasites Results in CD28 and CD40 Ligand Signaling That Controls IL-12-Dependent and -Independent T Cell Production of IFN-γ
    Carlos S. Subauste, Matthew Wessendarp · 2000 · The Journal of Immunology
  6. ANALYSIS OF THE B7 COSTIMULATORY PATHWAY IN ALLOGRAFT REJECTION1
    Thomas C. Pearson, Diane Z. Alexander, Matthias Corbascio, Rose C. Hendrix, Shannon C. Ritchie, Peter S. Linsley, D A Faherty, Christian P. Larsen · 1997 · Transplantation
  7. Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma
    T Tatsumi, Tetsuo Takehara, Kazuhiro Katayama, Kiyoshi Mochizuki, Masashi Yamamoto, Tatsuya Kanto, Yutaka Sasaki, Akinori Kasahara, Norio Hayashi · 1997 · Hepatology
  8. A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.
    Y Wu, Yuqi Guo, Yang Liu · 1993 · The Journal of Experimental Medicine
  9. Differential role of CD80 and CD86 on alveolar macrophages in the presentation of allergen to T lymphocytes in asthma
    Piero Emilio Balbo, M. Silvestri, Giovanni Arturo Rossi, Emanuele Crimi, Samuele E. Burastero · 2001 · Clinical & Experimental Allergy
  10. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
    Samuel M. Behar, Steven Anthony Porcelli, Evan M. Beckman, Michael B. Brenner · 1995 · The Journal of Experimental Medicine
  11. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen‐presenting cells (trans‐costimulation)
    Linna Ding, Ethan M. Shevach · 1994 · European Journal of Immunology
  12. CTLA-4 blockade: therapeutic potential in cancer treatments
    Ahmad A. Tarhini · 2010 · OncoTargets and Therapy
  13. T-cell activation: a multidimensional signaling network
    Su-Yi Tseng, Michael Loran Dustin · 2002 · Current Opinion in Cell Biology
  14. CD28, IL-2-Independent Costimulatory Pathways for CD8 T Lymphocyte Activation
    Homero Sepulveda, Adelheid Cerwenka, Tammy Morgan, Richard W Dutton · 1999 · The Journal of Immunology
  15. Prevention of Transplant Rejection
    Norberto Perico, Giuseppe Remuzzi · 1997 · Drugs
  16. Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with Ipilimumab
    Jon Bjoern, Nikolaj Juul Nitschke, Trine Zeeberg Iversen, Henrik Schmidt, Kirsten Fode, Inge Marie Svane · 2015 · OncoImmunology
  17. Clinical islet transplant: current and future directions towards tolerance
    Andrew M. James Shapiro, Sulaiman A. Nanji, Jonathan R. T. Lakey · 2003 · Immunological Reviews
  18. CD40 Activation Boosts T Cell Immunity In Vivo by Enhancing T Cell Clonal Expansion and Delaying Peripheral T Cell Deletion
    Joseph R. Maxwell, Jeff D. Campbell, Carol H. Kim, Anthony T. Vella · 1999 · The Journal of Immunology
  19. The B7 adhesion molecule is expressed on activated human T cells: Functional involvement in T‐T cell interactions
    Tony Wyss‐Coray, Daniela Mauri-Hellweg, Kaspar Baumann, Florence Bettens, Roland Grunow, Werner J. Pichler · 1993 · European Journal of Immunology
  20. Expression and function of B7‐1 (CD80) and B7‐2 (CD86) on human epidermal Langerhans cells
    Frédérique‐Marie Rattis, J. Navarro, Marie‐Jeanne Staquet, Colette Dezutter‐Dambuyant, Pascal Courtellemont, Gérard Redziniak, Daniel Schmitt · 1996 · European Journal of Immunology
  21. Costimulation Blockade
    Gillian Kinnear, Nick D. Jones, Kathryn J. Wood · 2012 · Transplantation
  22. Inflammatory and Infectious Syndromes Associated With Cancer Immunotherapies
    Jay Alan Fishman, John I Hogan, Marcela Valderrama Maus · 2018 · Clinical Infectious Diseases
  23. Antibodies as therapeutic agents: vive la renaissance!
    LH Stockwin, S Holmes · 2003 · Expert Opinion on Biological Therapy
  24. Regulation of T Cell Activation by CD28 and CTLA4
    Patricia J. Noel, Lawrence Boise, Craig B. Thompson · 1996 · Advances in experimental medicine and biology
  25. CD2 regulates responsiveness of activated T cells to interleukin 12.
    Jared Gollob, Jiaxun Li, Ellis L. Reinherz, Jerome Ritz · 1995 · The Journal of Experimental Medicine
  26. Regulatory T‐cell development in the tumor microenvironment
    Kota Itahashi, Takuma Irie, Hiroyoshi Nishikawa · 2022 · European Journal of Immunology
  27. Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analyses.
    L Lu, Michael Harrison Hsieh, Timothy B. Oriss, Penelope A. Morel, Thomas E. Starzl, A S Rao, Angus W. Thomson · 1995 · PubMed Central
  28. Immune checkpoint therapy for pancreatic cancer
    Henrik Johansson, Roland E. Andersson, Monika Posaric Bauden, Sarah Hammes, Stefan Holdenrieder, Daniel Ansari · 2016 · World Journal of Gastroenterology
  29. The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen
    Pablo Engel, John G. Gribben, G J Freeman, LJ Zhou, Yoshihiro Nozawa, M Abe, Lee Marshall Nadler, Haruki Wakasa, TF Tedder · 1994 · Blood
  30. Tolerogenicity of resting and activated B cells.
    K M Gilbert, William O. Weigle · 1994 · The Journal of Experimental Medicine
  31. CTLA-4 (CD152): A versatile receptor for immune-based therapy
    Holger Lingel, Monika Christine Brunner-Weinzierl · 2019 · Seminars in Immunology
  32. Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells
    Jessica Bourque, Daniel Hawiger · 2018 · Critical Reviews in Immunology
  33. Mecanismo de acción de abatacept: concordancia con su perfil clínico
    Gabriel Herrero‐Beaumont, María José Martínez Calatrava, Santos Castañeda · 2011 · Reumatología Clínica
  34. The Future of Organ and Tissue Transplantation
    David M. Harlan, Allan D. Kirk · 1999 · JAMA
  35. The Role of the CD40 Pathway in Alloantigen-Induced Hyporesponsiveness In Vivo
    Masanori Niimi, Thomas C. Pearson, Christian P. Larsen, Diane Z. Alexander, Diane L. Hollenbaugh, Alejandro A. Aruffo, Peter S. Linsley, Elaine Thomas, Kim Campbell, William C. Fanslow et al. · 1998 · The Journal of Immunology
  36. Safety of T-cell co-stimulation modulation with abatacept in patients with rheumatoid arthritis.
    Jean Sibilia, René Westhovens · 2007 · PubMed
  37. A negative regulatory function of B7 revealed in B7-1 transgenic mice
    Michael P. Sethna, Luk van Perijs, Arlene H. Sharpe, Abul K. Abbas, Gordon J. Freemant · 1994 · Immunity
  38. State of the art in anti-cancer mAbs
    Sebastián Matias Chiavenna, Juan Pablo Jaworski, A. Vendrell · 2017 · Journal of Biomedical Science
  39. Abatacept treatment does not exacerbate chronic Mycobacterium tuberculosis infection in mice
    Carolyn Bigbee, Daryl G. Gonchoroff, George Vratsanos, Steven G. Nadler, Helen G. Haggerty, JoAnne L. Flynn · 2007 · Arthritis & Rheumatism
  40. T cell co-stimulation and in vivo tolerance
    Deborah J. Lenschow, Jeffrey A. Bluestone · 1993 · Current Opinion in Immunology
  41. Localization in situ of the co‐stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue
    Florry A. Vyth‐Dreese, Trees A. M. Dellemijn, Donné M. Majoor, Daphne de Jong · 1995 · European Journal of Immunology
  42. Mechanisms of Peripheral T Cell Tolerance
    Luk Van Parijs, Victor L. Perez, Abul K. Abbas · 2007 · Novartis Foundation symposium
  43. Can Co‐stimulated Tumor Immunity be Therapeutically Efficacious?
    Karl Erik Hellströum, Ingegerd Hellström, Lieping Chen · 1995 · Immunological Reviews
  44. Exploiting Apoptosis for Therapeutic Tolerance Induction
    Daniel R. Getts, Derrick P. McCarthy, Stephen D. Miller · 2013 · The Journal of Immunology
  45. Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
    Alten, Rieke, Bingham, Clifton O., Cohen, Stanley B., Curtis, Jeffrey R., Kelly, Sheila, Wong, Dennis, Genovese, Mark C. · 2016 · BMC Musculoskeletal Disorders
  46. Initiating mechanisms of food allergy: Oral tolerance versus allergic sensitization
    Femke van Wijk, Leon M J Knippels · 2006 · Biomedicine & Pharmacotherapy
  47. Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go
    Angela Vasaturo, Stefania Di Blasio, Deborah G. A. Peeters, Coco C. H. de Koning, I. Jolanda M. de Vries, Carl Gustav Figdor, Stanleyson V. Hato · 2013 · Frontiers in Immunology
  48. T Cell Costimulatory Blockade
    Hrefna Guðmundsdóttir, Laurence A. Turka · 1999 · Journal of the American Society of Nephrology
  49. Reciprocal expression of co‐stimulatory molecules, B7‐1 and B7‐2, on murine T cells following activation
    Mercy R. Prabhu Das, Scott S. Zamvil, Frank Borriello, Howard L. Weiner, Arlene H. Sharpe, Vijay Kumar Kuchroo · 1995 · European Journal of Immunology
  50. T cell costimulatory pathways
    Mohamed H. Sayegh, Laurence A. Turka · 1995 · Journal of the American Society of Nephrology
  51. Emerging Immunotherapy for Acute Myeloid Leukemia
    Rikako Tabata, SungGi Chi, Junichiro Yuda, Yosuke Minami · 2021 · International Journal of Molecular Sciences
  52. Flavonoid Naringenin: A Potential Immunomodulator for Chlamydia trachomatis Inflammation
    Abebayehu N. Yilma, Shree Ram Singh, Lisa A. Morici, Vida A. Dennis · 2013 · Mediators of Inflammation
  53. Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade
    Yu-Chen Chuang, Jen‐Chih Tseng, Li-Rung Huang, Chun‐Ming Huang, Chi‐Ying F. Huang, Tsung‐Hsien Chuang · 2020 · Frontiers in Immunology
  54. Normal Responsiveness of CTLA-4-Deficient Anti-Viral Cytotoxic T Cells
    Martin F. Bachmann, Paul D. Waterhouse, Daniel E. Speiser, Kim McKall-Faienza, Tak W. Mak, Pamela S. Ohashi · 1998 · The Journal of Immunology
  55. Antigen presentation by parenchymal cells: a route to peripheral tolerance?
    Federica M. Murelii‐Berg, Robert Ian Lechler · 1999 · Immunological Reviews
  56. IL-10 Is Required for Development of Protective Th1 Responses in IL-12-Deficient Mice upon Candida albicans Infection
    Antonella Mencacci, Elio Cenci, Giuseppe Del Sero, Cristiana Fé d’Ostiani, Paolo Mosci, Giorgio Trinchieri, Luciano Adorini, Luigina R. Romani · 1998 · The Journal of Immunology
  57. Engineering of a Novel Anti-CD40L Domain Antibody for Treatment of Autoimmune Diseases
    Jenny Xie, Aaron P. Yamniuk, Virna Borowski, Robert Kuhn, Vojkan Susulic, Sandra Rex‐Rabe, Xiaoxia Yang, Xiadi Zhou, Yifan Zhang, Kathleen M. Gillooly et al. · 2014 · The Journal of Immunology
  58. Compensation for Decreased Expression of B7 Molecules onLeishmania infantum-Infected Canine Macrophages Results in Restoration of Parasite-Specific T-Cell Proliferation and Gamma Interferon Production
    Elena Pinelli, Victor P. M. G. Rutten, Martijn W.P. Bruysters, Peter F. Moore, Elis Joost Ruitenberg · 1999 · Infection and Immunity
  59. The Soluble Form of CTLA-4 from Serum of Patients with Autoimmune Diseases Regulates T-Cell Responses
    Rita Simone, Giampaola Pesce, Princey Antola, Margarita Rumbullaku, Marcello Bagnasco, Nicola Bizzaro, Danièle Saverino · 2014 · BioMed Research International
  60. Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation
    Caroline Martin, Martine Plat, Véronique Nerrière‐Daguin, Flora Coulon, Svetlana Uzbekova, Éric Venturi, Françoise Condé, Jean‐Michel Hermel, Philippe Hantraye, Laurent Tesson et al. · 2005 · Transgenic Research
  61. Anti-CTLA-4 treatment induces IL-10-producing ICOS + regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis
    Caroline Coquerelle, Guillaume Oldenhove, Valérie Acolty, Julie Denoeud, Georgette Vansanten, J‐M Verdebout, Andrew L. Mellor, Jeffrey A. Bluestone, Muriel Moser · 2009 · Gut
  62. From T‐cell activation signals to signaling control of anti‐cancer immunity
    Shane J. F. Cronin, Josef Martin Penninger · 2007 · Immunological Reviews
  63. Abatacept Mechanism of Action: Concordance With Its Clinical Profile
    Gabriel Herrero‐Beaumont, María José Martínez Calatrava, Santos Castañeda · 2012 · Reumatología Clínica (English Edition)
  64. Checkpoint immunotherapy by nivolumab for treatment of metastatic melanoma
    Veerendra Koppolu, VeneelaKrishna Rekha Vasigala · 2018 · Journal of Cancer Research and Therapeutics
  65. Co-signal Molecules in T-Cell Activation
    Miyuki Azuma · 2019 · Advances in experimental medicine and biology
  66. Cytokine regulation of astrocyte function: in‐vitro studies using cells from the human brain
    Francesca Aloisi, Giovanna Borsellino, Alessandra Carè, Ugo Testa, Paolo Gallo, Giobanni Russo, C Peschle, Giulio Levi · 1995 · International Journal of Developmental Neuroscience
  67. Perinatal Blockade of B7-1 and B7-2 Inhibits Clonal Deletion of Highly Pathogenic Autoreactive T Cells
    Jianxin Gao, Huiming Zhang, Xue‐Feng Bai, Jing Wen, Xincheng Zheng, Jinqing Liu, Pan Zheng, Yang Liu · 2002 · The Journal of Experimental Medicine
  68. Protection against lethal toxic shock by targeted disruption of the CD28 gene.
    Bhaskar Saha, David M. Harlan, Kelvin P. Lee, Carl H. June, Ryo Abe · 1996 · The Journal of Experimental Medicine
  69. Effect of CTLA‐4 chimeric protein on rat autoimmune anti‐glomerular basement membrane glomerulonephritis
    Kazuhiro Nishikawa, Peter S. Linsley, A. Bernard Collins, Ivan Stamenkovic, Robert T. McCluskey, Giuseppe A. Andres · 1994 · European Journal of Immunology
  70. Association of Autoimmune Thyroid Disease with Microsatellite Markers for the Thyrotropin Receptor Gene and CTLA-4 in Japanese Patients
    Takashi Akamizu, Michèle M. Sale, Stephen S. Rich, Hitorni Hiratani, Jaeduk Yoshimura Noh, Naotetsu Kanamoto, Misa Saijo, Yoshihiro Miyamoto, Yoshihiko Saito, Kazuwa Nakao et al. · 2000 · Thyroid
  71. Regulation of costimulation in the era of butyrophilins
    Heather A. Arnett, Sydney M. Escobar, Joanne L. Viney · 2009 · Cytokine
  72. The presence of costimulatory molecules CD86 and CD28 in rheumatoid arthritis synovium
    Ming Fei Liu, Hitoshi Kohsaka, Hiroshi Sakurai, Miyuki Azuma, Ko Okumura, Ichiro Saito, Nobuyuki Miyasaka · 1996 · Arthritis & Rheumatism
  73. The function of costimulatory molecules and the development of IL-4-producing T cells
    William C. Gause, Mark J. Halvorson, Pin Lu, Rebecca J. Greenwald, Peter S. Linsley, Joseph F. Urban, Fred D. Finkelman · 1997 · Immunology Today
  74. Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
    Cai, Xin, Zhan, Huajie, Ye, Yuguang, Yang, Jinjin, Zhang, Minghui, Li, Jing, Zhuang, Yuan · 2021 · Frontiers in Genetics
  75. Genetic Susceptibility to Atopic Dermatitis
    Chikako Kiyohara, Keiko Tanaka, Yoshihiro Miyake · 2008 · Allergology International
  76. CTLA4Ig: a novel inhibitor of costimulation
    Maria Dall’Era, John C. Davis · 2004 · Lupus
  77. T helper cell activation and human retroviral pathogenesis
    Karen F.T. Copeland, Jonathan Luke Heeney · 1996 · Microbiological Reviews
  78. Functional and Selective Targeting of Adenovirus to High-Affinity Fcγ Receptor I-Positive Cells by Using a Bispecific Hybrid Adapter
    Christina Ebbinghaus, Ahmed Al-Jaibaji, Elisabeth Operschall, Angelika Schöffel, Isabelle S. Peter, Urs F. Greber, Silvio Hemmi · 2001 · Journal of Virology
  79. Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-γ, interleukin-7, or B7-1-transfected tumor cells
    Edward Visse, Peter Siesjö, Bengt Widegren, Hans Olov Sjögren · 1999 · Cancer Gene Therapy
  80. Isolation and Function of Human Dendritic Cells
    Lisa A. Williams, William Egner, Derek N.J. Hart · 1994 · International review of cytology
  81. B7/BB-1 is a leucocyte differentiation antigen on human dendritic cells induced by activation.
    Derek N.J. Hart, Gary C. Starling, Virginia L. Calder, N S Fernando · 1993 · PubMed Central
  82. The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment
    Sara Isabel Pai, Dan Paul Zandberg, Scott Eric Strome · 2016 · Oral Oncology
  83. Belatacept: from rational design to clinical application
    Thomas Wekerle, Josep Maria Grinyo · 2011 · Transplant International
  84. The role of CTLA-4 and PD-1 in anti-tumor immune response and their potential efficacy against osteosarcoma
    Shengdong Wang, Hengyuan Li, Binghao Li, Tao Xie, Ting Zhu, Lingling Sun, Haiyong Ren, Zhaoming Ye · 2016 · International Immunopharmacology
  85. Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1
    Leonhardt Bauer, Barbara Bohle, Beatrice Jahn‐Schmid, Ursula Wiedermann, Angelika Daser, Harald E. Renz, Dietrich Kraft, Christof Ebner · 1997 · Clinical & Experimental Immunology
  86. CD28-B7-Mediated T Cell Costimulation in Chronic Cardiac Allograft Rejection
    Kyung‐Soo Kim, Mark Denton, Anil K. Chandraker, ANDREAS KNOFLACH, Rolando A. Milord, A. M. Waaga, Laurence A. Turka, Mary E. Russell, Robert Peach, Mohamed H. Sayegh · 2001 · American Journal Of Pathology
  87. CD6, a Rheostat-Type Signalosome That Tunes T Cell Activation
    Carine M. Gonçalves, Sónia N. Henriques, Rita F. Santos, Alexandre M. Carmo · 2018 · Frontiers in Immunology
  88. Interactions of T Cells with Fibroblast-Like Synoviocytes: Role of the B7 Family Costimulatory Ligand B7-H3
    Chinh N Tran, Seth G. Thacker, Deanna M. Louie, Jennifer A. Oliver, Peter T White, Judith Endres, Andrew G. Urquhart, Kevin C. Chung, David A. Fox · 2008 · The Journal of Immunology
  89. Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction
    Patricia M. Davis, Steven G. Nadler, Dawn K. Stetsko, Suzanne J. Suchard · 2007 · Clinical Immunology
  90. A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer
    Xi Li, Rouzheng Wang, Peiwen Fan, Xuan Yao, Ling Qin, Yanchun Peng, Miaomiao Ma, Neil Asley, Xuimei Chang, Yaning Feng et al. · 2019 · Frontiers in Oncology
  91. Cytokines and Peripheral Tolerance to Alloantigen
    Margaret J. Dallman, K J Wood, Kimikazu Hamano, Andrew Bushell, Peter J. Morris, Matthew J. A. Wood, Harry M. Charlton · 1993 · Immunological Reviews
  92. Immune checkpoint inhibitors in non-small cell lung cancer: A bird's eye view
    Humera Memon, Bhoomika M. Patel · 2019 · Life Sciences
  93. Sphingomyelin‐ceramide turnover in CD28 costimulatory signaling
    Gordon Chan, Atsuo Ochi · 1995 · European Journal of Immunology
  94. IMPROVED SURVIVAL OF BIOLISTICALLY TRANSFECTED MOUSE ISLET ALLOGRAFTS EXPRESSING CTLA4-Ig OR SOLUBLE FAS LIGAND1
    Anita L. Gainer, Wilma L. Suarez‐Pinzon, Wei‐Ping Min, John R. Swiston, Camille L. Hancock-Friesen, Gregory S. Korbutt, Ray V. Rajotte, Garth L. Warnock, John F. Elliott · 1998 · Transplantation
  95. The perspective of immunotherapy
    Christian U. Blank · 2014 · Current Opinion in Oncology
  96. Neuroinflammation in Parkinson’s Disease: Triggers, Mechanisms, and Immunotherapies
    Tai Wang, Changhe Shi, Haiyang Luo, Huimin Zheng, Liyuan Fan, Mibo Tang, Yun Su, Jing Yang, Chengyuan Mao, Yuming Xu · 2021 · The Neuroscientist
  97. Diverse Mechanisms Regulate the Surface Expression of Immunotherapeutic Target CTLA-4
    Helga Schneider, Christopher E. Rudd · 2014 · Frontiers in Immunology
  98. Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives
    Gaël S. Roth, Thomas Decaens · 2017 · European Journal of Cancer
  99. Long-term culture of monoclonal human T lymphocytes: models for immunosenescence?
    Adibzadeh, Medi, Pohla, Heike, Rehbein, Arnika, Pawelec, Graham · 1995 · Mechanisms of Ageing and Development
  100. Current status of xenotransplantation research and the strategies for preventing xenograft rejection
    Qiao Zhou, Ting Li, Kaiwen Wang, Qi Zhang, Zhuowen Geng, Shaoping Deng, Chunming Cheng, Yi Wang · 2022 · Frontiers in Immunology